Arak, Hacı, and Tülay Kuş. “Prognostic and Predictive Significance of HER2-Low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy”. European Journal of Therapeutics 30, no. 5 (May 23, 2024): 662–674. Accessed January 2, 2025. https://eurjther.com/index.php/home/article/view/2151.